76.65 USD
↗ 1.50 (1.99%)LIVE (AS OF 03:22 PM EDT)
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
KNSANASDAQ • USD
Market: OPEN
Shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) are trading at $76.65. Our models show a "Neutral" technical signal alongside a "Buy" fundamental rating. Notable factors include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Sep 15, 2026.
Open?$75.06
High?$77.05
Low?$74.94
Prev. Close?$75.15
Volume?241.5K
Avg. Volume?469.4K
VWAP?$76.54
Rel. Volume?0.51x
Bid / Ask
Bid?$76.59 × 100
Ask?$77.04 × 100
Spread?$0.45
Midpoint?$76.82
Valuation & Ratios
Market Cap?5.9B
Shares Out?48.3M
Float?38.9M
Float %?84.2%
P/E Ratio?72.70
P/B Ratio?8.96
EPS?$1.03
Dividend?0.41%
Ex-Dividend?N/A
News
Profile
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Address
105 PICCADILLY, SECOND FLOOR
LONDON, W1J 7NJ
Phone: (781) 431-9100
LONDON, W1J 7NJ
Phone: (781) 431-9100
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?73
Short Sent.?59
Piotroski F-Score?5/9Mixed
Altman Z-Score?15.87Safe
Confidence?70%Moderate
Short InterestHigh
Short % of Float?9.74%Elevated
Short Interest?3.8M
Days to Cover?8.7
Free Float38.9M
Avg Daily Volume436.1K
Settlement Date2026-08-31
Financial Health
Current Ratio?3.90Strong
Quick Ratio?3.49Strong
Cash Ratio?1.03Strong
Debt/Equity?0.13Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score44/100
P/E?72.7PRICEY▾
Peers100
S&P6
P/B?8.96HIGH▾
Peers100
S&P21
P/S?6.97FAIR▾
Peers100
S&P17
P/FCF?32.1FAIR▾
Peers100
S&P26
EV/EBITDA?56.6HIGH▾
Peers100
S&P3
EV/Sales?6.87HIGH▾
Peers100
S&P21
Returns & Efficiency
ROE?12.3%STRONG▾
Peers50
S&P44
ROA?9.0%STRONG▾
Peers50
S&P71
Cash Flow & Enterprise
FCF?$182.8M
Enterprise Value?$5.8B
Fundamentals ratios updated end of day